Segment Information (Tables)
|
6 Months Ended |
Dec. 31, 2022 |
|---|
| Segment Reporting [Abstract] |
|
| Disaggregation of Revenue [Table Text Block] |
| | | | | | | | | | | | | Three Months Ended December 31, | | (in millions) | 2022 | | 2021 | | Pharmaceutical Distribution and Specialty Solutions (1) (2) | $ | 47,391 | | | $ | 41,164 | | | Nuclear and Precision Health Solutions (3) | 282 | | | 211 | | Pharmaceutical segment revenue | 47,673 | | | 41,375 | | | Medical distribution and products (4) | 3,099 | | | 3,446 | | | Cardinal Health at-Home Solutions | 698 | | | 639 | | Medical segment revenue | 3,797 | | | 4,085 | | | Total segment revenue | 51,470 | | | 45,460 | | | Corporate (5) | (1) | | | (3) | | | Total revenue | $ | 51,469 | | | $ | 45,457 | |
| | | | | | | | | | | | | Six Months Ended December 31, | | (in millions) | 2022 | | 2021 | | Pharmaceutical Distribution and Specialty Solutions (1) (2) | $ | 92,938 | | | $ | 80,778 | | | Nuclear and Precision Health Solutions (3) | 563 | | | 419 | | Pharmaceutical segment revenue | 93,501 | | | 81,197 | | | Medical distribution and products (4) | 6,239 | | | 7,013 | | | Cardinal Health at-Home Solutions | 1,336 | | | 1,221 | | Medical segment revenue | 7,575 | | | 8,234 | | | Total segment revenue | 101,076 | | | 89,431 | | | Corporate (5) | (4) | | | (6) | | | Total revenue | $ | 101,072 | | | $ | 89,425 | |
(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services." (2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division. (3)Increase from prior year relates to new product launches and changes in revenue recognition presentation from agent to principal for certain customer contracts. (4)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division. (5)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
|
| Revenue from External Customers by Geographic Areas [Table Text Block] |
The following tables present revenue by geographic area: | | | | | | | | | | | | | Three Months Ended December 31, | | (in millions) | 2022 | | 2021 | | United States | $ | 50,333 | | | $ | 44,382 | | | International | 1,137 | | | 1,078 | | | Total segment revenue | 51,470 | | | 45,460 | | | Corporate (1) | (1) | | | (3) | | | Total revenue | $ | 51,469 | | | $ | 45,457 | |
| | | | | | | | | | | | | Six Months Ended December 31, | | (in millions) | 2022 | | 2021 | | United States | $ | 98,810 | | | $ | 87,223 | | | International | 2,266 | | | 2,208 | | | Total segment revenue | 101,076 | | | 89,431 | | | Corporate (1) | (4) | | | (6) | | | Total revenue | $ | 101,072 | | | $ | 89,425 | |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
|
| Segment Profit by Reportable Segment |
The following tables present segment profit by reportable segment and Corporate: | | | | | | | | | | | | | Three Months Ended December 31, | | (in millions) | 2022 | | 2021 | | Pharmaceutical (1) | $ | 464 | | | $ | 426 | | | Medical | 17 | | | 50 | | | Total segment profit | 481 | | | 476 | | | Corporate | (600) | | | (1,426) | | | Total operating loss | $ | (119) | | | $ | (950) | |
| | | | | | | | | | | | | Six Months Ended December 31, | | (in millions) | 2022 | | 2021 | | Pharmaceutical (1) | $ | 895 | | | $ | 832 | | | Medical | 9 | | | 173 | | | Total segment profit | 904 | | | 1,005 | | | Corporate | (886) | | | (1,540) | | | Total operating earnings/(loss) | $ | 18 | | | $ | (535) | |
(1)Pharmaceutical segment profit during the three and six months ended December 31, 2021 was positively impacted by a $16 million judgment for lost profits related to an ordinary course intellectual property rights claim.
|
| Assets by Reportable Segment |
The following table presents total assets for each reportable segment and Corporate at: | | | | | | | | | | | | | (in millions) | December 31,
2022 | | June 30,
2022 | | Pharmaceutical | $ | 28,992 | | | $ | 26,409 | | | Medical (1) | 10,757 | | | 11,632 | | | Corporate | 4,733 | | | 5,837 | | | Total assets | $ | 44,482 | | | $ | 43,878 | |
|